NCT06926673
- Conditions
- Neoplasms
- Locations
-
- GSK Investigational SIte Nashville, Tennessee, United States
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Brampton, Ontario, Canada
- GSK Investigational Site Toronto, Ontario, Canada